Researchers have developed a device that could determine how soon patients should be fed following surgery. Patients with the intestinal problem postoperative ileus fall sick if they eat too soon after surgery and must stay in the hospital for an additional two to three days.
Soon, there will be a device to cure some forgetfulness if the Department of Defense's four-year grant of up to $40 million succeeds in fostering implants and electronic interfaces that diagnose and treat memory loss due to traumatic brain injury.
The University of California, Los Angeles, has received $4 million from the Eli and Edythe Broad Foundation, $2 million of which will go to the Broad Stem Cell Research Center with the other $2 million supporting the university's Division of Digestive Diseases.
The University of California and a Chinese company will launch a high-end medical lab in Shanghai expected to handle molecular diagnostics and other tests for Chinese patients. They're billing the initiative as the first of its kind between a Chinese company and a U.S. academic medical center.
To get through a dense jungle, you'll need to clear a path. Similarly, to get past a thick network of scaffolding that often prevents drugs from reaching cancer cells, UCLA researchers have developed nanoparticles capable of clearing a path for drugs to pass through to a tumor.
GlaxoSmithKline's latest attempt to enlist the academic community in its translational research efforts has won a chilly reception from the upper echelon of UCLA.
Chronic or nonhealing sores or wounds can be caused by a number of factors, including diabetes, surgery, severe skin irritations, burns, traumatic accidents or impaired blood flow. As diabetes and obesity rates in the U.S. soar, these types of wounds are becoming more common, and the cost to treat them is on the rise.
A newly identified protein with virus-fighting properties could help prevent deadly pathogenic viruses, such as HIV and Ebola, among others.
Researchers at the University of California, Los Angeles, have created what could be a new way to treat cancer, combining nanotechnology with a genetic kill switch.
NanoSmart Pharmaceuticals has hooked up with UCLA to develop targeted drugs for cancer and other serious life-threatening diseases.